S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
Retirees Face “Income Destruction” (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
Retirees Face “Income Destruction” (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
Retirees Face “Income Destruction” (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
Retirees Face “Income Destruction” (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
OTCMKTS:POLXF

Polydex Pharmaceuticals - POLXF Stock Forecast, Price & News

$0.79
-0.01 (-1.25%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.79
$0.79
50-Day Range
$0.72
$0.89
52-Week Range
$0.72
$1.15
Volume
1,300 shs
Average Volume
4,378 shs
Market Capitalization
$2.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
POLXF stock logo

About Polydex Pharmaceuticals (OTCMKTS:POLXF) Stock

Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry. In addition, the company develops Ushercell, a high molecular weight cellulose sulphate for topical vaginal use primarily in the prevention and transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies. Further, it supplies ferric hydroxide and hydrogenated dextran solutions. The company sells its products through independent distributors and wholesalers, as well as directly to companies. The company was formerly known as Polydex Chemicals Limited and changed its name to Polydex Pharmaceuticals Limited in March 1984. Polydex Pharmaceuticals Limited was incorporated in 1979 and is based in Toronto, Canada.

Receive POLXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

POLXF Stock News Headlines

Polydex Pharmaceuticals Inc (POLXF)
See More Headlines
Receive POLXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

POLXF Company Calendar

Today
8/11/2022
Fiscal Year End
1/31/2023

Industry, Sector and Symbol

Industry
Industrial inorganic chemicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:POLXF
Fax
N/A
Employees
22
Year Founded
N/A

Profitability

Net Income
$-550,000.00
Pretax Margin
-8.15%

Debt

Sales & Book Value

Annual Sales
$4.23 million
Book Value
$1.75 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.71 million
Optionable
Not Optionable
Beta
0.44

Key Executives

  • Mr. George G. Usher (Age 63)
    Chairman, CEO & Pres
  • Ms. Sharon L. Wardlaw (Age 69)
    COO, Treasurer & Sec.
  • Mr. David P. Jamestee C.A. (Age 56)
    CPA, Chief Financial Officer













POLXF Stock - Frequently Asked Questions

How have POLXF shares performed in 2022?

Polydex Pharmaceuticals' stock was trading at $1.00 on January 1st, 2022. Since then, POLXF stock has decreased by 21.0% and is now trading at $0.79.
View the best growth stocks for 2022 here
.

What is Polydex Pharmaceuticals' stock symbol?

Polydex Pharmaceuticals trades on the OTCMKTS under the ticker symbol "POLXF."

How do I buy shares of Polydex Pharmaceuticals?

Shares of POLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Polydex Pharmaceuticals' stock price today?

One share of POLXF stock can currently be purchased for approximately $0.79.

How much money does Polydex Pharmaceuticals make?

Polydex Pharmaceuticals (OTCMKTS:POLXF) has a market capitalization of $2.71 million and generates $4.23 million in revenue each year. The company earns $-550,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.

How can I contact Polydex Pharmaceuticals?

Polydex Pharmaceuticals' mailing address is 421 COMSTOCK ROAD, TORONTO A6, M1L 2H5. The official website for the company is www.polydex.com. The company can be reached via phone at (416) 755-2231 or via email at polydexir@gmail.com.

This page (OTCMKTS:POLXF) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.